These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 1418018

  • 1. Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement.
    Buyon JP, Tamerius J, Belmont HM, Abramson SB.
    Arthritis Rheum; 1992 Sep; 35(9):1028-37. PubMed ID: 1418018
    [Abstract] [Full Text] [Related]

  • 2. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
    Buyon JP, Tamerius J, Ordorica S, Young B, Abramson SB.
    Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
    [Abstract] [Full Text] [Related]

  • 3. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
    Manzi S, Rairie JE, Carpenter AB, Kelly RH, Jagarlapudi SP, Sereika SM, Medsger TA, Ramsey-Goldman R.
    Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
    [Abstract] [Full Text] [Related]

  • 4. Complement activation in patients with systemic lupus erythematosus without nephritis.
    Mollnes TE, Haga HJ, Brun JG, Nielsen EW, Sjöholm A, Sturfeldt G, Mårtensson U, Bergh K, Rekvig OP.
    Rheumatology (Oxford); 1999 Oct; 38(10):933-40. PubMed ID: 10534542
    [Abstract] [Full Text] [Related]

  • 5. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
    Chiu YY, Nisihara RM, Würzner R, Kirschfink M, de Messias-Reason IJ.
    J Investig Allergol Clin Immunol; 1998 Oct; 8(4):239-44. PubMed ID: 9777539
    [Abstract] [Full Text] [Related]

  • 6. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
    Brodeur JP, Ruddy S, Schwartz LB, Moxley G.
    Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
    [Abstract] [Full Text] [Related]

  • 7. Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples.
    Kolb WP, Morrow PR, Tamerius JD.
    Complement Inflamm; 1989 Dec; 6(3):175-204. PubMed ID: 2472921
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of detection of complement activation products in evaluating SLE activity.
    Nagy G, Brózik M, Varga L, Füst G, Kirschfink M, Kiss E, Gergely P.
    Lupus; 2000 Dec; 9(1):19-25. PubMed ID: 10713643
    [Abstract] [Full Text] [Related]

  • 9. Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy.
    Abramson SB, Buyon JP.
    Am J Reprod Immunol; 1992 Dec; 28(3-4):183-7. PubMed ID: 1285875
    [Abstract] [Full Text] [Related]

  • 10. Complement fragment C4d and Bb levels in inflammatory skin diseases (e.g. SLE, atopic dermatitis, erythroderma and pustulosis palmaris et plantaris) for assessment of complement activation.
    Takematsu H, Tagami H.
    Tohoku J Exp Med; 1991 Apr; 163(4):263-8. PubMed ID: 1831937
    [Abstract] [Full Text] [Related]

  • 11. Classical pathway complement activation in Kawasaki syndrome.
    Kohsaka T, Abe J, Asahina T, Kobayashi N.
    J Allergy Clin Immunol; 1994 Feb; 93(2):520-5. PubMed ID: 8120278
    [Abstract] [Full Text] [Related]

  • 12. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients.
    Vallhonrat H, Williams WW, Cosimi AB, Tolkoff-Rubin N, Ginns LC, Wain JC, Preffer F, Olszak I, Wee S, Delmonico FL, Pascual M.
    Transplantation; 1999 Jan 27; 67(2):253-8. PubMed ID: 10075589
    [Abstract] [Full Text] [Related]

  • 13. Generation of the membrane attack complex during haemodialysis: impact of classical and alternative pathway components.
    Hauser AC, Derfler K, Stockenhuber F, Janata O, Balcke P.
    Clin Sci (Lond); 1990 Nov 27; 79(5):471-6. PubMed ID: 2174314
    [Abstract] [Full Text] [Related]

  • 14. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
    Gyongyossy-Issa MI, McLeod E, Devine DV.
    J Lab Clin Med; 1994 Jun 27; 123(6):859-68. PubMed ID: 8201264
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of complement activation between tuberculous and malignant pleuritis].
    Hidaka K, Abe M, Tanaka T, Mitsuyama T, Hara N, Hara N.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr 27; 33(4):379-83. PubMed ID: 7791265
    [Abstract] [Full Text] [Related]

  • 16. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
    Ho A, Barr SG, Magder LS, Petri M.
    Arthritis Rheum; 2001 Oct 27; 44(10):2350-7. PubMed ID: 11665976
    [Abstract] [Full Text] [Related]

  • 17. Lymphocyte-bound complement activation products as biomarkers for diagnosis of systemic lupus erythematosus.
    Liu CC, Kao AH, Hawkins DM, Manzi S, Sattar A, Wilson N, Ahearn JM.
    Clin Transl Sci; 2009 Aug 27; 2(4):300-8. PubMed ID: 20161444
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
    Li J, An L, Zhang Z.
    Clin Exp Rheumatol; 2014 Aug 27; 32(1):48-53. PubMed ID: 23981509
    [Abstract] [Full Text] [Related]

  • 19. The value of complement activation products in the assessment of systemic lupus erythematosus flares.
    Porcel JM, Ordi J, Castro-Salomo A, Vilardell M, Rodrigo MJ, Gene T, Warburton F, Kraus M, Vergani D.
    Clin Immunol Immunopathol; 1995 Mar 27; 74(3):283-8. PubMed ID: 7859418
    [Abstract] [Full Text] [Related]

  • 20. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions.
    Hara N, Abe M, Inuzuka S, Kawarada Y, Shigematsu N.
    Chest; 1992 Oct 27; 102(4):1060-4. PubMed ID: 1395743
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.